Encouraging Competition Through Generic Drugs
FDA clarifies its generic drug approval process in an effort to encourage market competition.
Increasing the Legitimacy of the World Health Organization
International organizations need clear principles to guide their response to public health emergencies.
France’s Health Crisis Is a Democracy Crisis, Too
France’s inadequate response to COVID-19 is a failure to prepare, not a failure to predict.
Cost-Benefit Analysis Supports Continuing the National Shutdown
The lives saved by four more weeks of social distancing requirements outweigh the harms to the economy.
The Delayed Response in Wuhan Reveals Legal Holes
Chinese public health and emergency laws contributed to delayed responses to COVID-19.
Comparing Nations’ Responses to COVID-19
Leading scholars from around the world discuss the administrative law and regulatory dimensions to the global response to COVID-19.
Obligation Alleviation During the COVID-19 Crisis
The most surprising regulatory dimension of the coronavirus crisis may center on the lifting of rules.
Voting Amid a Pandemic
As COVID-19 persists, governments must decide whether, when, where, and how to hold elections.
Combatting Covert Chemistry Operations
To curb overdoses and drug trafficking, the DEA proposes regulations for a chemical precursor to fentanyl.
COVID-19 and the Defense Production Act
A 70-year old law could help in the battle against the coronavirus outbreak.
EPA Proposes to Accelerate Its Permit Appeal Process
A proposed rule to speed up administrative decision-making could have unintended consequences.
ISIS the Art Dealer
Stronger regulations are needed to combat antiquities trafficking that finances terrorist activity.